×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
CTLT – catalent, inc. (US:NYSE)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
CTLT
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
12/18
10:42 am
ctlt
Novo Holdings completes purchase of Catalent [Seeking Alpha]
Neutral
Report
Novo Holdings completes purchase of Catalent [Seeking Alpha]
12/18
09:22 am
ctlt
Novo Holdings Completes Acquisition of Catalent [Yahoo! Finance]
Neutral
Report
Novo Holdings Completes Acquisition of Catalent [Yahoo! Finance]
12/18
08:57 am
ctlt
Novo Holdings Completes Acquisition of Catalent
Neutral
Report
Novo Holdings Completes Acquisition of Catalent
12/17
06:48 am
ctlt
MindMed doses first subject in trial of tablets for generalised anxiety disorder [Yahoo! Finance]
Low
Report
MindMed doses first subject in trial of tablets for generalised anxiety disorder [Yahoo! Finance]
12/16
07:10 am
ctlt
MindMed Announces First Patient Dosed in Phase 3 Voyage Study of MM120 in Generalized Anxiety Disorder (GAD) [Yahoo! Finance]
Low
Report
MindMed Announces First Patient Dosed in Phase 3 Voyage Study of MM120 in Generalized Anxiety Disorder (GAD) [Yahoo! Finance]
12/14
11:57 am
ctlt
Regulatory conditions on Novo Holdings' $16.5 billion Catalent deal fulfilled, companies say [Yahoo! Finance]
Low
Report
Regulatory conditions on Novo Holdings' $16.5 billion Catalent deal fulfilled, companies say [Yahoo! Finance]
12/14
12:13 am
ctlt
Novo Nordisk A/S: The acquisition of Catalent by Novo Holdings, and the related acquisition by Novo Nordisk of three manufacturing sites from Novo Holdings, is cleared to close [Yahoo! Finance]
Low
Report
Novo Nordisk A/S: The acquisition of Catalent by Novo Holdings, and the related acquisition by Novo Nordisk of three manufacturing sites from Novo Holdings, is cleared to close [Yahoo! Finance]
12/14
12:11 am
ctlt
Catalent and Novo Holdings Fulfill All Regulatory Closing Conditions for Pending Transaction [Yahoo! Finance]
Low
Report
Catalent and Novo Holdings Fulfill All Regulatory Closing Conditions for Pending Transaction [Yahoo! Finance]
Date
Time
Symbol
Headline
Impact
12/18
02:10 pm
ctlt
Form 4 Catalent, Inc. For: Dec 18 Filed by: Gennadios Aristippos
Neutral
Report
Form 4 Catalent, Inc. For: Dec 18 Filed by: Gennadios Aristippos
12/18
02:08 pm
ctlt
Form 4 Catalent, Inc. For: Dec 18 Filed by: McErlane David
Neutral
Report
Form 4 Catalent, Inc. For: Dec 18 Filed by: McErlane David
12/18
02:06 pm
ctlt
Form 4 Catalent, Inc. For: Dec 18 Filed by: Hatzfeld Michael
Neutral
Report
Form 4 Catalent, Inc. For: Dec 18 Filed by: Hatzfeld Michael
12/18
02:01 pm
ctlt
Form 4 Catalent, Inc. For: Dec 18 Filed by: Gunther Scott
Neutral
Report
Form 4 Catalent, Inc. For: Dec 18 Filed by: Gunther Scott
12/18
01:56 pm
ctlt
Form 4 Catalent, Inc. For: Dec 18 Filed by: Ferraro Joseph Anthony
Neutral
Report
Form 4 Catalent, Inc. For: Dec 18 Filed by: Ferraro Joseph Anthony
12/18
01:21 pm
ctlt
Form 4 Catalent, Inc. For: Dec 18 Filed by: STAHL JACK L
Neutral
Report
Form 4 Catalent, Inc. For: Dec 18 Filed by: STAHL JACK L
12/18
01:18 pm
ctlt
Form 4 Catalent, Inc. For: Dec 18 Filed by: Ryan Michelle R
Neutral
Report
Form 4 Catalent, Inc. For: Dec 18 Filed by: Ryan Michelle R
12/18
01:09 pm
ctlt
Form 4 Catalent, Inc. For: Dec 18 Filed by: Okey Stephanie
Neutral
Report
Form 4 Catalent, Inc. For: Dec 18 Filed by: Okey Stephanie
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
3/17
Catalent Partners with Biohaven on New Fast-Dissolve Migraine Treatment
10.2%
4/29 Catalent Signs Agreement with Johnson & Johnson to be U.S. Manufacturing Partner for Lead COVID-19 Vaccine Candidate 9.5%
3/9 Catalent, Inc. to Present at the Barclays Global Healthcare Conference 7.8%
6/21 Catalent Inc (NYSE: CTLT) was upgraded by analysts at Jefferies Financial Group Inc from a "hold" rating to a "buy" rating. 5.9%
12/17 Catalent to Host Workshop to Discuss Accelerating Early Drug Development through Consultant Collaboration 4.9%
12/18 Catalent Inc (NYSE: CTLT) was upgraded by analysts at Zacks Investment Research from a "sell" rating to a "hold" rating. 4.2%
3/3 Form 8-K Catalent, Inc. For: Mar 02 3.9%
4/13 Catalent Publishes Fiscal 2019 Corporate Responsibility Report 3.6%
3/2 Catalent Inc (NYSE: CTLT) is now covered by analysts at Deutsche Bank AG. They set a "hold" rating and a $59.00 price target on the stock. 3.5%
1/13 Age-Appropriate Formulation Development for Pediatric Trials: Challenges and Considerations, Upcoming Webinar Hosted by Xtalks 3.1%
4/29 Catalent Signs Agreement with Johnson & Johnson to be U.S. Manufacturing Partner for Lead COVID-19 Vaccine Candidate 9.5%
3/9 Catalent, Inc. to Present at the Barclays Global Healthcare Conference 7.8%
6/21 Catalent Inc (NYSE: CTLT) was upgraded by analysts at Jefferies Financial Group Inc from a "hold" rating to a "buy" rating. 5.9%
12/17 Catalent to Host Workshop to Discuss Accelerating Early Drug Development through Consultant Collaboration 4.9%
12/18 Catalent Inc (NYSE: CTLT) was upgraded by analysts at Zacks Investment Research from a "sell" rating to a "hold" rating. 4.2%
3/3 Form 8-K Catalent, Inc. For: Mar 02 3.9%
4/13 Catalent Publishes Fiscal 2019 Corporate Responsibility Report 3.6%
3/2 Catalent Inc (NYSE: CTLT) is now covered by analysts at Deutsche Bank AG. They set a "hold" rating and a $59.00 price target on the stock. 3.5%
1/13 Age-Appropriate Formulation Development for Pediatric Trials: Challenges and Considerations, Upcoming Webinar Hosted by Xtalks 3.1%
TOP News Decliners
3/17
Vectura Group PLC (VEGPF) CEO Will Downie on Q4 2019 Results - Earnings Call Transcript [Seeking Alpha]
-13.9%
8/27 Catalent Earnings Unexpectedly Rise [Investor's Business Daily] -5.4%
2/27 Catalent Announces Supplying Blueprint Medicines' Precision Therapy AYVAKIT™ (avapritinib) -4.8%
4/30 Form 8-K Catalent, Inc. For: Apr 30 -4.2%
5/7 Q3/2019 3/31/2019 EPS 0.220 ZacksConsensus 0.420 ActVsEst (0.200) - Miss -3.9%
2/24 Catalent's Senior Vice President & Chief Financial Officer, Wetteny Joseph, Inducted as a Member of the Executive Leadership Council -3.6%
2/3 Catalent, Inc. Announces Public Offering of Common Stock -3.5%
2/20 Catalent to Host Workshop Demonstrating Advantages of Integrated Biologics Development Solutions in London, U.K. -3.1%
3/27 Catalent Inc (NYSE: CTLT) had its price target lowered by analysts at Morgan Stanley from $67.00 to $57.00. They now have an "overweight" rating on the stock. -3.0%
4/20 Catalent Inc (NYSE: CTLT) is now covered by analysts at Royal Bank of Canada. They set an "outperform" rating on the stock. -2.9%
8/27 Catalent Earnings Unexpectedly Rise [Investor's Business Daily] -5.4%
2/27 Catalent Announces Supplying Blueprint Medicines' Precision Therapy AYVAKIT™ (avapritinib) -4.8%
4/30 Form 8-K Catalent, Inc. For: Apr 30 -4.2%
5/7 Q3/2019 3/31/2019 EPS 0.220 ZacksConsensus 0.420 ActVsEst (0.200) - Miss -3.9%
2/24 Catalent's Senior Vice President & Chief Financial Officer, Wetteny Joseph, Inducted as a Member of the Executive Leadership Council -3.6%
2/3 Catalent, Inc. Announces Public Offering of Common Stock -3.5%
2/20 Catalent to Host Workshop Demonstrating Advantages of Integrated Biologics Development Solutions in London, U.K. -3.1%
3/27 Catalent Inc (NYSE: CTLT) had its price target lowered by analysts at Morgan Stanley from $67.00 to $57.00. They now have an "overweight" rating on the stock. -3.0%
4/20 Catalent Inc (NYSE: CTLT) is now covered by analysts at Royal Bank of Canada. They set an "outperform" rating on the stock. -2.9%
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: